ZIDOVUDINE
Generic: ZIDOVUDINE
Aurobindo Pharma LimitedManufacturer
ORALRoute
ZIDOVUDINEActive Substance
2006-03-27Original Approval
ZIDOVUDINE is FDA application ANDA078128, sponsored by AUROBINDO PHARMA LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
FOETAL EXPOSURE DURING PREGNANCY
1,725 reports
2
VIROLOGIC FAILURE
851 reports
3
DRUG RESISTANCE
740 reports
4
PATHOGEN RESISTANCE
663 reports
5
EXPOSURE DURING PREGNANCY
660 reports
6
ANAEMIA
639 reports
7
VIRAL MUTATION IDENTIFIED
637 reports
8
DRUG EXPOSURE DURING PREGNANCY
601 reports
9
MATERNAL EXPOSURE DURING PREGNANCY
528 reports
10
PREMATURE BABY
527 reports